UBS Maintains Sell on Ambev, Raises Price Target to $2.9

Benzinga Newsdesk www.benzinga.com Positive 83.4%

Neg 0% Neu 0% Pos 83.4%

UBS analyst Rodrigo Alcantara maintains Ambev (NYSE:ABEV) with a Sell and raises the price target from $2.65 to $2.9.

Comments

No comments yet. Be the first!